Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.clim.2021.108803 http://scihub22266oqcxt.onion/10.1016/j.clim.2021.108803 34302970!8294696!34302970     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+Immunol 2021 ; 230 (ä): 108803 Nephropedia Template TP {{tp|p=34302970|t=2021. COVID-19 prevalence and outcomes in patients receiving biologic therapies at an infusion center in New York City |pdf=|usr=}}{{34302970}} gab.com Text COVID-19 prevalence and outcomes in patients receiving biologic therapies at an infusion center in New York City JO: Clin Immunol http://www.kidney.de/pget.php?&tw=1&pmid=34302970 #FOAvip To better understand COVID-19 infection in patients receiving biologic and immunomodulatory therapies, we evaluated prevalence and outcomes for symptomatic cases of COVID-19 at a large therapeutic infusion center in New York City during the height of the pandemic. 2074 patients received treatment with biologic infusions at our center between March and May 2020, and 34 patients developed symptomatic COVID-19 infection, for an overall low rate of 1.64%. The majority of infections and deaths were in a small subset of patients with a primary immunodeficiency. Patients with inflammatory or autoimmune conditions requiring biologic therapies tended to have mild cases. Higher inflammatory responses were observed in patients who died. Twit Text FOAVip COVID-19 prevalence and outcomes in patients receiving biologic therapies at an infusion center in New York City ????Clin Immunol http://www.kidney.de/pget.php?&tw=1&pmid=34302970 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34302970 #FOAvip English Wikipedia <ref>{{Cite pmid|34302970}}</ref> COVID-19 prevalence and outcomes in patients receiving biologic therapies at an infusion center in New York City #MMPMID34302970 Harada K; Ho HE; Cunningham-Rundles C Clin Immunol 2021[Sep]; 230 (ä): 108803 PMID34302970show ga To better understand COVID-19 infection in patients receiving biologic and immunomodulatory therapies, we evaluated prevalence and outcomes for symptomatic cases of COVID-19 at a large therapeutic infusion center in New York City during the height of the pandemic. 2074 patients received treatment with biologic infusions at our center between March and May 2020, and 34 patients developed symptomatic COVID-19 infection, for an overall low rate of 1.64%. The majority of infections and deaths were in a small subset of patients with a primary immunodeficiency. Patients with inflammatory or autoimmune conditions requiring biologic therapies tended to have mild cases. Higher inflammatory responses were observed in patients who died. |*Ambulatory Care Facilities[MESH] |*SARS-CoV-2[MESH] |Autoimmune Diseases/*therapy[MESH] |Biological Factors/*administration & dosage[MESH] |Biomarkers[MESH] |COVID-19/complications/*epidemiology/mortality[MESH] |Comorbidity[MESH] |Female[MESH] |Humans[MESH] |Incidence[MESH] |Inflammation/metabolism[MESH] |Male[MESH] |Middle Aged[MESH] |New York City/epidemiology[MESH]COVID-19 prevalence and outcomes in patients receiving biologic therap(epmc).pdf DeepDyve Pubget Overpricing